JENNIFER HUGHES: Open Payments
NPI 1023894896 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,379 in 102 payments from 31 companies in 2025. Trend: 2023 $90 · 2024 $1,017 · 2025 $2,379
Food & beverage: $1,835Education: $544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $423 |
| Janssen Biotech, Inc. | 10 | $367 |
| Novartis Pharmaceuticals Corporation | 9 | $163 |
| Lilly USA, LLC | 3 | $156 |
| Eisai Inc. | 4 | $110 |
| Genentech USA, Inc. | 4 | $88 |
| Exelixis Inc. | 4 | $85 |
| Stemline Therapeutics Inc. | 4 | $81 |
| Daiichi Sankyo Inc. | 4 | $76 |
| SOBI, INC | 3 | $66 |
Products named: RYBREVANT, DARZALEX, VERZENIO, Enhertu, IMFINZI, Lenvima, CABOMETYX, KISQALI.
Industry payments across KS — which companies pay providers there.
